Диссертация (1174317), страница 20
Текст из файла (страница 20)
/ Y. Feng, G. Cheng, H. Wang et al. //Osteoporosis International. – 2017. V. 28. – I.5. – P. 1641–5248.Flather, M. SENIORS Investigators. Randomized trial to determine the effectof nebivolol on mortality and cardiovascular hospital admission in elderlypatients with heart failure (SENIORS). / M. Flather, M. Shibata, A. Coats et al.// European Journal of Heart Failure. – 2005. – V.
26. – I. 3. – P. 215–22549.Fohtung, R. Bone Mineral Density and Risk of Heart Failure in Older Adults:The Cardiovascular Health Study. / R. Fohtung, D. Brown, W. Koh et al. //JournalAmericanHeartAssociation.–2017.–Режимдоступа:https://doi.org/10.1161/JAHA.116.00434450.Folstein, M. "Mini-mental state". A practical method for grading the cognitivestate of patients for the clinician». / M.
Folstein, S. Folstein, P. McHugh. //Journal of Psychiatric Research. – 1975. – V. 12. – I. 3. – P. 189–9851.Fredericks, S. Effects of the characteristics of teaching on the outcomes of heartfailure patients education interventions: A systematic review. / S. Fredericks,H. Beanlands, K. Spalding et al. // European journal of cardiovascular nursing.– 2010. V. 9.
– P. 30-3752.Fried, L. Untangling the concepts of disability, frailty, and comorbidity:implications for improved targeting and care. / L. Fried, L. Ferrucci, J. Darer etal. // Journals of Gerontology Series A-Biological Sciences & MedicalSciences. – 2004. – V. 59. – I. 3. - P. 255-26353.Geers, H. Measuring and predicting medication adhearence using dispensingdata and patient beliefs. / H. Geers.
// - 2012. - (Doctoral dissertation). –Режимдоступа:http://igitur-archive.library.uu.nl/dissertations/2012-0126-200348/geers.pdf14254.Gerber, Y. Osteoporotic fractures and heart failure in the community. / Y.Gerber, L. Melton, S. Weston et al. // The American Journal of Medicine. –2011. – V. 124. – I. 5. – P. 418-2555.Gjesing, A. Patient adherence to evidence-based pharmacotherapy in systolicheart failure and the transition of follow-up from specialized heart failureoutpatient clinics to primary care. / A.
Gjesing, M. Schou, C. Torp-Pedersen etal. // European Journal Heart Failure. – 2013. - V.15. – I. 6. – P. 671-67856.Guralnik, J. Lower-extremity function in persons over the age 70 years as apredictor of subsequent disability. / J. Guralnik, E. Simonsick, M. Salive. //New England Journal of Medicine. -1995. - V. 332. - I.9. – P. 556-56157.Guyatt, G. How sould we measure function in patients with chronic heart andlung disease? / G.
Guyatt, P. Thompson et al. // Journal of Chronic Diseases. –1985. – V. 38. - S. 6. – P. 517-52458.Halil, M. Cognitive аspects of frailty: mechanisms behind the link betweenfrailty and cognitive impairment. / M. Halil, M. Kizilarslanoglu, E. Kuyumcu Eet al. // The journal of nutrition, health & aging. – 2015. – V. 19. – I. 3. – P.276-28359.Harvey, L.Incidence, timing and impact of comorbidity on second hipfracture: a population‐based study. / L. Harvey, B. Toson, R. Mitchell et al. //ANZ Journal of Surgery. – 2017.
- V. 88. – P. 577-58160.Inouye, S. Geriatric syndromes: clinical, research and policy implications of acore geriatric concept. / S. Inouye, M. Studenski, M. Tinetti. // Journal of theAmerican Geriatrics Society. – 2007. –V. 55. – I. 5. – P. 780–79161.Jacobs, J. Frailty, cognitive impairment and mortality among the oldest old. / J.Jacobs, A. Cohen, E. Elin-Mor et al.
// The journal of nutrition, health & aging.– 2011. – V. 15. – I. 8. – P. 678-8214362.Kidney International Supplements. – 2013. - Volume 3. - Issue 1. – Режимдоступа: doi:10.1038/kisup.2012.4863.Koudstaal, S. Prognostic burden of heart failure recordede in primary care,acute hospital admissions, or both: a population-based linked electronic healthrecord cohort study in 2,1 million people. / S. Koudstaal,M.
Pujades-Rodrigues, S. Denaxas et al. // European Journal of Heart Failure. – 2017. - V.19.- P. 1119-112764.Lainscak, M. Nonpharmacologic measures and drug compliance in patientswith heart failure: data from the Euro Heart Failure Survey. / M. Lainscak, J.Cleland, M. Lenzen. // American Journal of Cardiology. – 2007. - V. 99. - I. 6.– P. 31–3765.Lalić, J. Medication adherence in outpatients with arterial hypertension. / J.Lalić, R. Radovanović, B. Mitić et al. // Acta Facultatis Medicae Naissensis. –2013.
– V. 30. – I. 4. – P. 209-21866.Lang, R. Recommendations for Cardiac Chamber Quantification byEchocardiography in Adults: An Update from the American Society ofEchocardiography and the European Association of Cardiovascular Imaging. /R. Lang, L. Badano, V. Mor-Avi. // Journal of the American Society ofEchocardiography. – 2015.
– V. 28. – I. 1. - P. 1-3967.Laux, G. Co- and multimorbidity patterns in primary care based on episodes ofcare: results from the German CONTENT project. / G. Laux, T. Kuehlein, T.Rosemann et al. // BMC Health Services Research. – 2008. – Режим доступа:https://doi.org/10.1186/1472-6963-8-1468.Lazzarini, V. Heart Failure in elderly patients: distinctive features andunresolved issues.
/ V. Lazzarini, R. Mentz, M. Fiuzat et al. // European Journalof Heart Failure. – 2013. - V. 15. – I. 7. – P. 717-72369.Leistner, D. Elevated levels of the mediator of catabolic bone remodelingRANKL in the bone marrow environment link chronic heart failure with144osteoporosis. / D. Leistner, F. Seeger, A. Fischer et al. // Circulation: HeartFailure. – 2012. – V. 5 – P. 769–77770.Leng, S.
IL-6-independent association of elevated serum neopterin levels withprevalent frailty in community-dwelling older adults. / S. Leng, X. Tian, A.Matteini et al. // Age and Ageing. – 2011. – V. 40. – I. 4. – P. 475–48171.Levey, A. A new equation to estimate glomerular filtration rate. / A. Levey, L.Stevens, C. Schmid et al. // Annals of Internal Medicine. – 2009. –V.
150. –I. 9.– P. 604-61272.Liu, L. Serum 25-hydroxyvitamin D concentration and mortality from heartfailure and cardiovascular disease, and premature mortality from allcause inUnited States adults. / L. Liu, M. Chen, S. Hankins et al. // American Journal ofCardiology. – 2012. V. 110. – P. 834–83973.Löfdahl,E.Osteoporosisfollowinghearttransplantationandimmunosuppressive therapy. / E.
Löfdahl, C. Rådegran. // TransplantationReviews. – 2017. – V. 31. – I. 4. - P. 232-23974.Luttik, M. Long-term follow-up in optimally treated and stable heart failurepatients: primary care vs. heart failure clinic. Results of the COACH-2 study. /M. Luttik, T. Jaarsma, P. van Geel et al. // European Journal of Heart Failure. –2014. - V. 16. – P.
1241–124875.Lyons, K. The unrecognized burden of osteoporosis-related vertebral fracturesin patients with heart failure. / K. Lyons, S. Majumdar, J. Ezekowitz. //Circulation: Heart Failure. – 2011. V. 4. – P. 419-42976.Maggioni, A. ARNO Observatory. The real-world evidence of heart faiure:findings from 41413 patients of the ARNO database. / A. Maggioni, F. Orso, S.Calabria et al. // Journal of Heart Failure.
– 2016. – V. 18. – I. 5. – P. 402-41077.Majumdar, S. Heart failure is a clinically and densitometrically independentrisk factor for osteoporotic fractures: population-based cohort study of 45,509subjects. / S. Majumdar, J. Ezekowitz, L. Lix, W. Leslie// The Journal of145Clinical Endocrinology & Metabolism. - 2012.
–Режим доступа: DOI:10.1210/jc.2011-305578.Mamas, M. Do patients have worse outcomes in heart failure than in cancer? Aprimary care-based cоhort study with 10-year follow-up in Scotland. / M.Mamas, M. Sperrin, M. Watson. // European Journal of Heart Failure.
– 2017.– V. 19. – I. 9. – P. 1095-110479.McLennan, S. Prognostic importance of cognitive impairment in chronic heartfailure patients: Does specialist management make a difference? / S.McLennan, S. Pearson, J. Cameron et al. // European Journal of Heart Failure.– 2006. - V. 8. – P. 494-50180.McMurray, J. ESC guidelines for the diagnosis and treatment of acute andchronic heart failure 2012: the Task Force for the Diagnosis and Treatment ofAcute and Chronic Heart Failure 2012 of the European Society of Cardiology.Developed in collaboration with the HeartFailure Association (HFA) of theESC. / J.
McMurray, S. Adamopoulos, S. Anker. // European Journal of HeartFailure. – 2012. – V. 14. – I. 8. – P. 803–86981.McMurray, J. Heart failure with preserved ejection fraction: Clinicalcharacteristics of 4133 patients enrolled in the I-PRESERVE trial.
/ J.McMurray , P. Carson, M. Komajda. European Journal of Heart Failure. –2008. - V.10. – I. 2. - P. 149-15682.McMurray, J.Review of the current state of the art in heart failure. / j.McMurray, M. Pfeffer. // Heart failure. Lancet. – 2005. – V. 365. – P. 1877–188983.Mentz, R. Noncardiac Comorbidities in Heart Failure With Reduced VersusPreserved Ejection Fraction / R.
Mentz, P. Jacob, T. Kelly et al. // Journal ofthe American College of Cardiology. – V. 64 – I. 21. – P. 2281-229314684.Morisky, D. Concurrent and predictive validity of a self-reported measure ofmedication adherence. / D. Morisky, L .Green, D. Levine. // Med Care.-1986. – V. 24. – I.
1. – P. 67-7485.Morley, J. Frailty and sarcopenia: The new geriatric giants. / J. Morley. // RevInves Clin. – 2016. – V. 68. – P. - 59-6786.Morley, J.A simple frailty questionnaire (FRAIL) predicts outcomes in middleaged African Americans. / L. Fried, L. Ferrucci, J. Darer. // Journal NutritionHealth Aging.
– 2012. – V. 16. – I. 7. – P. 601–60887.Muzzarelli, S. Adherence to the medical regime in patients with heart failure. /S. Muzzarelli, H. Rocca, O. Pfister et al. // European Journal Heart Failure. –2010. – V. 12. – P. 389-39688.Ni, H. Recent trends in Heart Failure related mortality: Unated States, 2000 2014. / H. Ni H, J. Xu. // NCHS Data brief. – 2015. - № 231. - P. 1-889.Nohria, A. Observation is never obsolete. / A. Nohria, L. Stevenson.
// JACC:Heart Failure. – 2014. – V. 2. – P. 32-3490.Oudejans, I. Comorbidity drives mortality in newly diagnosed heart failure: astudy among geriatric outpatients. / I. Oudejans, A. Mosterd, N. Zuithoff et al.// Journal of cardiac failure. – 2012. – V. 18. – P. 47–5291.Pandya. K. Fibrosis, not cell size, delineates beta-myosin heavy chainreexpression during cardiac hypertrophy and normal aging in vivo. / Pandya K,Kim HS, Smithies O. Proceedings of the National Academy of Sciences. –2006. – Режим доступа: https://www.pnas.org/content/103/45/16864.92.Pazos-López, P. The causes, consequences, and treatment of left or right heartfailure. / P. Pazos-López, J.
Peteiro-Vázquez, A. Carcía-Campos et al. //Vascular Health and Risk Management. – 2011. – V. 7. – P.237-25493.Pialoux, T. Screening tools for frailty in primary health care: a systematicreview. / T. Pialoux, J. Govard, B. Lesourd. // Geriatrics GerontologyInternational. – 2012. – V. 12. – I. 2. – P. 189–19714794.Poliykov, D. S. EPOHA-HSN epidemiological program: a decompensation ofchronic heart failure in real clinical practice (EPOHA-D-HSN). / D.S.Poliykov, I.V. Fomin, F. Valikulova. // Magazine Heart Failure. – 2016. – V.17.
– I. 5. – P. 299–30595.Ponikowski, P. 2016 ESC Guidelines for the diagnosis and treatment of acuteand chronic heart failure. The Task Force for the diagnosis and treatment ofacute and chronic heart failure of the European Society of Cardiology (ESC).Developed with the special contribution of the Heart Failure Association (HFA)of the ESC.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
